LAB FY 2016 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

FY 2016 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$104M-8.9% YoY

Gross Profit

$58M55.9% margin

Operating Income

-$73M-70.1% margin

Net Income

-$76M-72.8% margin

EPS (Diluted)

$-2.62

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$44M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$306M

Total Liabilities

$253M

Stockholders' Equity

$53M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$104M	$115M	-8.9%
Gross Profit	$58M	$68M	-14.2%
Operating Income	-$73M	-$50M	-45.9%
Net Income	-$76M	-$53M	-42.5%